Research Articles

Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3
stats4

Search for:

     IGF-I
24 records.
Article ID PMID Source Title Publish Year
A01925 34560554 Biomed Pharmacother Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis. 2021 Details
A03110 34126247 Endocr Pract High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency. 2021 Details
A14476 29395967 Growth Horm IGF Res Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. 2018 Details
A15404 28927302 Scand J Gastroenterol IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study. 2017 Details
A15859 28678199 Int J Mol Sci The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. 2017 Details
A17606 27721459 Sci Rep IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. 2016 Details
A17786 27594563 Postepy Hig Med Dosw (Online) New peptides players in metabolic disorders. 2016 Details
A21549 25238938 Pathol Res Pract Histopathological aspects of liver under variable food restriction: has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development? 2014 Details
A22161 30736156 Expert Rev Endocrinol Metab Insulin-like growth factors (IGF-I and -II): new actors in the development of non-alcoholic fatty liver disease. 2014 Details
A22408 24607243 J Pediatr Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children. 2014 Details
A23998 23316084 J Clin Endocrinol Metab Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. 2013 Details
A24339 22986486 Endocr J Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. 2012 Details
A24641 22659415 Biochem Biophys Res Commun GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. 2012 Details
A25227 22077984 Clin Endocrinol (Oxf) Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. 2012 Details
A25234 22067322 Endocrinology Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. 2011 Details
A25454 21816784 J Clin Endocrinol Metab Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. 2011 Details
A27402 18462969 Growth Horm IGF Res Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. 2008 Details
A34223 24045151 J Hepatol A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. 2013 Details
A35433 20693650 J Alzheimers Dis Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. 2010 Details
A45248 27508202 J Hepatocell Carcinoma Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. 2015 Details
A46067 21303949 Endocrinology Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. 2011 Details
A49903 35603224 Front Immunol Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. 2022 Details
A52530 25941430 J Clin Exp Hepatol Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet. 2015 Details
A53128 11729749 Adv Anat Embryol Cell Biol Cooperation of liver cells in health and disease. 2001 Details